iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties on a catalog and custom basis; and offers a range of process development, manufacturing, filling and finishing, and bio analytic services. iBio, Inc. has a license agreement with Planet Biotechnology, Inc. to develop therapeutics for infectious diseases; collaboration agreement with The Texas A&M University System for the development of coronavirus disease 2019 vaccine candidates; license agreement with the University of Natural Resources and Life Sciences, Vienna; and collaboration agreement with CC-Pharming Ltd. The company is headquartered in Bryan, Texas. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of iBio Inc..
iBio Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of iBio Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of iBio Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of iBio Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of iBio Inc. and all latest updates of the company are provided.
The 2025 version of iBio Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 iBio Inc.- Key Facts
2.2 iBio Inc.- Geographic Locations
2.3 iBio Inc.- Subsidiaries and Affiliates
2.4 iBio Inc.- Business Divisions
2.5 iBio Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. iBio Inc. Strategic Analysis Review
3.1 iBio Inc.- Key Strategies
3.2 iBio Inc.- Company Outlook Statement
3.3 iBio Inc.- SWOT Analysis
3.3.1 iBio Inc.- Key Strengths
3.3.2 iBio Inc.- Key Weaknesses
3.3.3 iBio Inc.- Potential Opportunities
3.3.4 iBio Inc.- Potential Threats
3.4 iBio Inc.- Key Competitors
4. Business Description of the Company
4.1 iBio Inc.- Business Overview
4.2 iBio Inc.- Operations by Segment
5 Products and Services Details
5.1 iBio Inc.- Key Products
5.2 iBio Inc.- Key Service Areas
5.3 iBio Inc.- Key Brands
6 Company Developments
6.1 iBio Inc.- Company History
6.2 iBio Inc.- Latest Developments
7 Financial Analysis
7.1 iBio Inc.- Income Statements
7.2 iBio Inc.- Balance Sheet
7.3 iBio Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 iBio Inc.- Direct Competitors
8.2 iBio Inc.- Competitor Financial Ratios comparison
8.3 iBio Inc.- Competitor Stock Charts Comparison
8.4 iBio Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!